
Vasogliz M Plus 80mg/500mg Tablet SR
Marketer
Vasolife Healthcare
Salt Composition
Gliclazide (80mg) + Metformin (500mg)
Overview Vasogliz M Plus 80mg/500mg Tablet SR
Glycomet M Plus 80mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. To mitigate hypoglycemia, maintain regular meals and carry a readily available glucose source, such as candy or juice. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires medical consultation. Regular blood glucose monitoring is essential, alongside potential blood tests to assess blood cell counts and liver function as advised by your doctor.
Uses of Vasogliz M Plus 80mg/500mg Tablet SR
Adult-onset diabetes
Major Benefits of Vasogliz M Plus 80mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vasogliz M Plus 80mg/500mg Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with food.
Common Side effects of Vasogliz M Plus 80mg/500mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Dizziness
- Diarrhea
- Upper respiratory tract infection
- Nausea
- Flatulence
- Constipation
How to use Vasogliz M Plus 80mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vasogliz M Plus 80mg/500mg Tablet SR whole; do not chew, crush, or divide it. Administer this medication with a meal.
How Vasogliz M Plus 80mg/500mg Tablet SR works:
Gliclazide and Metformin, combined in the extended-release Vasogliz M Plus 80mg/500mg tablet, offer dual-action diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Vasogliz M Plus 80mg/500mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Use of Vasogliz M Plus 80mg/500mg SR tablets during pregnancy carries a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in critical circumstances where potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Vasogliz M Plus 80mg/500mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Vasogliz M Plus 80mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Vasogliz M Plus 80mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a reduced dose; the medication is contraindicated for those with severe hepatic dysfunction. Physician consultation is advised.
What if you forget to take Vasogliz M Plus 80mg/500mg Tablet SR :
Should you forget to take a Vasogliz M Plus 80mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vasogliz M Plus 80mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
